Posted by ABMN Staff on Mar 28th, 2024
HC Wainwright reiterated their buy rating on shares of 89bio (NASDAQ:ETNB – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. HC Wainwright currently has a $31.00 price objective on...
More of this article »